latest news releases from the newsroom
Millicom International Cellular
MIC Announces Closure of Mandatory Exchangeable Bond Offering
BERTRANGE, Luxembourg, Aug. 7, 2003 (PRIMEZONE) -- Millicom International Cellular S.A. ("Millicom" or "MIC") (Nasdaq:MICC), the global telecommunications investor, today announces that on August 7, 2003 the offering by its subsidiary Millicom Telecommunications S.A. of approximately SEK 2,556 million (US$310 million) of secured Notes mandatorily exchangeable into Series B shares of Tele2 AB, has closed.
Abrams Hospitality Marketing
TravelPak: 'Travel With Stephanie Abrams!' Expands to 2 Hour National Syndication on Business Talk Radio Sundays in the 6 to 8pm EST Slot
NEW YORK, August 7, 2003 (PRIMEZONE) -- (PRIMEPAK FEATURE) It has been a summer of celebrating, according to travel expert, Stephanie Abrams. "On July 6th, we celebrated the first anniversary of, "Travel With Stephanie Abrams!" in its one hour format, nationally syndicated, on Business Talk Radio, and Dave Isby, my on-air Traveling Companion, and I entered our second year on the air with excitement and enthusiasm," Abrams explains. "And then the call came!"
Industri-Matematik Intl. Corp
IMI Achieves Solid Progress in Company Goals
MT. LAUREL, N.J., and STOCKHOLM, Sweden, Aug. 7, 2003 (PRIMEZONE) -- Industri-Matematik International Corp. (Other OTC:IMIC) (IMI) today reported results for the first half of 2003, including significant financial and product gains that are the result of the company turnaround strategy. The initiative was marked by both IMI's appointment of Timothy Campbell as company president and CEO in January 2003 and the company's acquisition by Symphony Technology Group.
NeuroSearch -- Strategy Announcement and Raises its Full-Year Forecast for 2003
BALLERUP, Denmark, Aug. 7, 2003 (PRIMEZONE) -- NeuroSearch (Copenhagen:NEUS) is one of the world's leading biopharmaceutical companies in the research and development of new drugs against diseases of the central nervous system (CNS). NeuroSearch has recently reached a number of significant milestones in its current research and development programs and expects to enter into one or more new strategic alliances before the end of 2003.
Gambro: Navigant Biotechnologies launches website
STOCKHOLM, Sweden, Aug. 7, 2003 (PRIMEZONE) -- Gambro AB (Other OTC: GAMOF) (Other OTC:GAMBF) (Stockholm:GAMBaST), a leading international medical technology and healthcare company, today announced that Navigant Biotechnologies, Inc., a Denver, U.S.-based and wholly owned subsidiary of Gambro, Inc., has launched its new website: www.navigantbiotech.com. The new site includes links to a comprehensive group of scientific abstracts describing the company's breakthrough Mirasol(TM) Pathogen Reduction Technology (PRT). Mirasol PRT is a proprietary technology intended for use with donated blood components.
Sapa secures major order from IKEA valued at 400 MSEK
STOCKHOLM, Sweden, Aug. 7, 2003 (PRIMEZONE) -- Sapa Profiler AB, Vetlanda, Sweden, which manufactures and refines aluminium profiles, has secured another major order for a new product for the furniture giant IKEA. The order, valued at SEK 400 M, is the largest ever in Sapa's 40-year history.